Validus Cellular Therapeutics, Inc. is pioneering the use of cellular therapy for the treatment of drug-resistant, chronic bacterial infections. Cellular therapy approaches have been successful for oncology patients, and researchers at Colorado State University and the Anschutz Medical Campus discovered stem cells can also be activated to fight infections.
Colorado BioScience Association President and CEO, Elyse Blazevich, asked Ethan Mann, Chief Executive Officer of Validus Cellular Therapeutics, Inc. and CBSA Board Vice Chair, CBSA’s Key Questions for Life Sciences Innovators.
Q: Tell us about your company or organization.
A: I founded Validus in September 2019 along with Dr. Steven Dow and support from both Colorado State University and the University of Colorado. I was installed as the CEO of Validus while Dr. Dow maintained his role at…
Click here to view original post